Lanean...
No signs of immunoactivation in the cerebrospinal fluid during treatment with infliximab
Neuroinflammatory (demyelinating) disease is a rare but feared complication of treatment with anti‐tumour necrosis factor (TNF)α in patients with polyarthritis. In this study, blood and cerebrospinal fluid markers of inflammation were analysed in 10 people with polyarthritis before and during treatm...
Gorde:
| Egile Nagusiak: | , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMJ Group
2006
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1798287/ https://ncbi.nlm.nih.gov/pubmed/16606644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.055194 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|